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ABSTRACT
Staphylococcus aureus pathogenesis is directed by
regulatory proteins and RNAs. We report the case of
an RNA attenuating virulence and host uptake, pos-
sibly to sustain commensalism. A S. aureus sRNA,
SprC (srn 3610), reduced virulence and bacterial
loads in a mouse infection model. S. aureus deleted
for sprC became more virulent and increased bacte-
rial dissemination in colonized animals. Conversely,
inducing SprC expression lowered virulence and the
bacterial load. Without sprC, S. aureus phagocy-
tosis by monocytes and macrophages was higher,
whereas bacteria were internalized at lower yields
when SprC expression was stimulated. Without sprC,
higher internalization led to a greater number of
extracellular bacteria, facilitating colonization. SprC
expression decreased after phagocytosis, concur-
ring with the facilitated growth of bacteria lacking
the sRNA in the presence of an oxidant. The major
staphylococcal autolysin facilitates S. aureus uptake
by human phagocytes. ATL proved to be negatively
regulated by SprC. The SprC domains involved in
pairing with atl mRNA were analyzed. The addition of
ATL reduced phagocytosis of bacteria lacking sprC
with no effects on wild-type bacterial uptake, imply-
ing that SprC influences phagocytosis, at least in
part, by controlling ATL. Since the control of SprC
on ATL was modest, other factors must contribute to
atl regulation.
INTRODUCTION
Infected hosts sense the presence of pathogens and ac-
tivate immune defense mechanisms for survival. The im-
mune system relies on antimicrobial peptides, lytic enzymes,
complement activation and phagocyte recruitment. Upon
interaction of bacteria with host cell receptors, the host
cells protect and repair their DNA, prevent apoptosis and
secrete antimicrobial peptides. Subsequently, the release
of adhesins and chemo-attractants leads to phagocyte re-
cruitment at the infection site to trigger an inflammatory
response (1). Microorganisms have developed ingenious
mechanisms to fight and bypass the host signaling path-
ways and immune responses for survival and spread into
their hosts (2,3).
Staphylococcus aureus (S. aureus) is a Gram-positive
bacterium that rapidly acquires antibiotic resistances, be-
ing a worldwide health problem causing nosocomial and
community-associated infections. S. aureus has surface and
secreted components that compromise the host immune re-
sponses, allowing bacterial escape (4,5). Staphylococcal ad-
herence to the host cells represents a prerequisite for their
uptake. S. aureus can be internalized and survive in vari-
ous host cells. This represents a critical factor for persistence
and also when infections recidivate (6). The ability of S. au-
reus to escape from the host lysosomal degradationmachin-
ery and to persist intracellularly for long time periods is an
essential step during infection. If engulfed by neutrophils,
the intracellular bacteria can resist reactive oxygen interme-
diates, nitric oxide radicals, defensins and bactericidal pro-
teins (6). After S. aureus internalization in non-phagocytic
cells, the host cells up-regulate genes involved in innate im-
munity, antigen presentation and cell signaling (7). Upon
internalization, S. aureus also reprograms gene expression
(8–10). Bacterial genes involved in capsule synthesis, oxida-
tive stress and virulence are up-regulated following inges-
tion of the pathogen (7,9). After S. aureus uptake by the
human lung epithelial cells, bacterial genes involved in cell
division and nutrient transport are down-regulated whereas
genes involved in iron scavenging and virulence are up-
regulated. During infection, S. aureus generates many vir-
ulence factors whose timing and expression levels are tuned
by dozens of regulatory proteins andRNAs (sRNAs).S. au-
reus expresses around 159 sRNAs (11,12) recently compiled
into the SRD database (13) with, for the most part, no asso-
ciated functions. These sRNAs are expressed from the core
and variable accessory genome including Pathogenicity Is-
lands and transposons (14). Some sRNAs either stimulate
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(15) or decrease (16) bacterial virulence in animal models of
infection and others influence antibiotic resistance (17).
In this report, we provide evidence that the Small
pathogenicity island rna C, SprC, alias srn 3610 (13), when
expressed by a S. aureus strain isolated from a human infec-
tion, diminishes bacterial virulence and spread in an animal
model of septicemia. An isogenic strain lacking sprC be-
comes more virulent and complementation of the sRNA re-
stores a lower virulence phenotype. SprC also reduces S. au-
reus phagocytosis by human monocytes and macrophages.
The sRNA disfavors bacterial resistance to an oxidative
stress, concurrent with extinction of SprC expression after
host cell uptake. The staphylococcal autolysin (ATL) func-
tions as an adhesin/invasin and binds the heat shock cog-
nate proteinHsc70 host cellular receptor (18). At themolec-
ular level, SprC interacts with the atl mRNA, in turn in-
hibiting ATL expression through a direct pairing interac-
tion between SprC and the atl mRNA. The SprC phago-
cytosis phenotype is mediated, at least in part, by ATL.
Overall, SprC attenuates bacterial virulence and host cell
phagocytosis. It suggests that this regulatory RNA, when
expressed, may favors commensalism with the host.
MATERIALS AND METHODS
Strains, culture conditions, genetic manipulations and oxida-
tive stress experiments
All the bacterial strains and plasmids used are listed in Sup-
plementary Table S1. S. aureus strains were grown at 37◦C
in brain heart infusion broth (BHI, Oxoid). When neces-
sary, chloramphenicol and erythromycin were added at a
10 g/ml concentration. For the oxidative stress, overnight
cultures were diluted (1/100), incubated with 5 mM hy-
drogen peroxide (Aldrich Chemical, St Louis, MO) and
optical density was measured using the spectrophotome-
ter Biotek Synergy 2. A chromosomal gene disruption
mutant was constructed by deletion of the targeted gene
and insertion of an erythromycin-resistance gene by us-
ing the temperature-sensitive vector pBT2 (19) according
to (15). Double-crossover events corresponding to the de-
sired gene disruptions were confirmed by polymerase chain
reaction (PCR) and sequenced. In all the sRNA overex-
pression genetic constructions, the RNAs are expressed
from their endogenous promoters. In pCN35sprC and
pCN38sprC, the nucleotide sequence of sprC containing
300 upstream nucleotides was amplified from Newman ge-
nomic DNA as a 460-bp fragment possessing EcoRI and
PstI restriction sites at each end. The PCR product was
cloned in pCN35erm and pCN38cat. E. coli DH5 were
transformed with pCN35sprC and pCN38sprC and se-
lected for ampicillin resistance. The plasmids pCN35-sprC
and pCN38-sprC were transferred into RN4220 and se-
lected for erythromycin and chloramphenicol resistance re-
spectively, then finally transferred to Newman WT and
Newman sprC.
S. aureus FITC labeling and microscopy
Bacteria were labeled with fluorescein isothiocyanate
(FITC) for the phagocytosis assay. 50 ml of cultured cells
(mid-log phase, OD600nm = 2) were harvested by cen-
trifugation. The cell pellet was washed with phosphate-
buffered saline (PBS) and re-suspended in 1 ml of
carbonate/bicarbonate buffer (pH 9.5, 0.1 M Na2CO3
and 0.2 M NaHCO3). The FITC (Sigma Chemical Co.,
St. Louis, Mo.) was dissolved in dimethyl sulfoxide at 10
mg/ml. 100 l of this solution was added to 500 l of the
bacterial suspension. The mixture was rotated at 180 rpm
for 1 h at room temperature. Bacteria were then washed
twice in PBS to remove the unbound fluorochrome and re-
suspended in 500 l of HBSS (Hanks Balanced Salt So-
lution). Aliquots were prepared, frozen and stored in the
dark until used. Aliquots were thawed just before use. Di-
lutions of stock suspensions of FITC-labeled bacteria or
control bacteria were plated on agar to determine the num-
ber of CFU/ml. Coverslips were mounted with Vectashield
mounting medium including DAPI (Vector Laboratories,
Burlingame, CA). Staining was viewed with an inverted
confocal microscope (DMIRE2, Leica) equipped with a
63XNA 1.4 objective lens using the LS 3D software (Le-
ica). Images were analyzed using the ‘MetaMorph’ (Molec-
ular Devices, Downington, PA) and Volocity (Perkin Elmer,
version 6.0.1) software.
Human macrophages production
THP1 human monocytes were obtained from ATCC
(Rockville, MD) and maintained at 37◦C with 5% CO2 in
RPMI 1640 (Invitrogen, Carlsbad, USA) containing 10%
FCS (Biowest). The THP1 cells were treated with PMA (20
ng/ml) (Sigma) for 3 days to stimulate their differentiation
into macrophages. The THP1 monocytes were efficiently
differentiated into adherent macrophages, as evidenced by
light microscopy.
Samples preparation, flow cytometry and phagocytosis as-
says in the human THP1 and macrophages
Human THP1 cells (106 cells) were incubated with 107
bacteria in RPMI, 10% human serum AB (SAB) (Insti-
tut Jacques Boy, Reims, France) to stimulate opsonization,
for different times, as indicated, at 37◦C, 180 rpm. The ex-
tracellular bacteria were lysed by lysostaphin (10 g/ml)
for 10 min and the cells were washed with RPMI, 10%
SAB and with PBS. At the indicated time points, the THP1
cells containing intracellular S. aureus were lysed for to-
tal RNA extraction. The cells were fixed in PBS / 4%
paraformaldehyde and analyzed using a FC500 flow cy-
tometer and CXP Analysis Software (Beckman Coulter,
Villepinte, France). To quantify bacterial phagocytosis, the
human THP1 macrophages were infected with S. aureus at
a multiplicity of infection (MOI) of 1:25. Phagocytosis as-
says were carried out for 2 h at 37◦C, in the presence of 5%
CO2 in RPMI 1640 medium containing 10% human SAB.
Phagocytosis was stopped by putting the plates on ice and
washing the cells three times with ice-cold PBS. All the non-
phagocytosed bacteria were killed by culturing the human
cells for 24 h in a medium containing 50 g/ml gentamycin
(Sigma). Subsequently, the mediumwas removed from each
well and the cells were washed three times with PBS and in-
cubated with PBS/SDS 0.1% for 15 min to lyse the cells.
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The lysates were plated in various dilutions on BHI agar
plates. The colony counts were performed to determine the
number of intra- and extracellular bacteria. All the samples
were prepared and tested in triplicate. For the inhibition of
phagocytosis mediated by ATL, the macrophages were pre-
incubated with ATL in a concentration range of 5 to 50 nM
for 30 min at 37◦C, 5% CO2 prior to the infection with a S.
aureus strain lacking sprC expression (Newman ΔsprC).
Cytochalasin D treatment and intracellular bacteria counting
To study the role of the human cell cytoskeleton in S. au-
reus uptake and provide evidence for phagocytosis, human
THP1 macrophages were incubated with 2.5 and 5 g/ml
cytochalasin D (Sigma) for 60 min at 37◦C before S. aureus
interaction and also during the experiment. Human THP1
macrophages were infected with S. aureus and phagocyto-
sis was carried out for 2 h at 37◦C, 5% CO2, in RPMI 1640
medium. Phagocytosis was stopped by putting the plates
on ice and washing the cells three times with ice-cold PBS.
The remaining non-phagocytosed bacteria were killed by
adding 100 g/ml gentamycin (Sigma) and cytochalasin D
(1 to 2.5 g/ml, Sigma) in the medium for 60 min, at 37◦C,
5%CO2. Subsequently, themediumwas removed from each
well, the cells were washed with PBS and cold distilled wa-
ter was added to lyse the cells by repeated pipetting. The
lysates were plated, in various dilutions, on BHI agar plates
and incubated overnight at 37◦C to determine the number
of intracellular bacteria.
RNA extractions, Northern blots, reverse transcription and
qPCR assays
Isolated colonies were suspended in BHI and incubated at
37◦C overnight. The culture was diluted 1:100 then incu-
bated at 37◦C with agitation and stopped at various phases
of growth. RNA extraction was performed as described
(20). The DNA probes used to detect sRNA are listed
in Supplementary Table S2. Total RNA (10 g) was sep-
arated on denaturing 6% PAGE and transferred onto a
Zeta probe GT membrane (Bio-Rad) in 0.5× TBE. The
membranes were hybridizedwith specific 32P-labeled probes
in ExpressHyb solution (Clontech), washed, exposed and
scanned with a PhosphorImager (Molecular Dynamics).
Contaminating DNA was removed from RNA samples by
treatment with DNase (DNase amplification grade, InVit-
rogen, Carlsbad, USA) according to the manufacturer’s
protocol. Twomicrograms of RNAwas used for first strand
cDNA synthesis using the High-Capacity cDNA Archive
Kit (Applied Biosystems, Foster City, USA) following the
manufacturer’s protocols. Real-time quantitative PCR was
performed with the fluorescent dye SYBR Green method-
ology using the Real Master Mix (Eppendorf) and the
Mastercycler realplex (Eppendorf). Supplementary Table
S3 shows primer pairs for each transcript chosen with the
Primer 3 program (http://frodo.wi.mit.edu/cgi-bin/primer3/
primer3 www.cgi). Gene specificity of each pair of primers
was checked by comparing their sequences to the GenBank
database using the program BLASTN (http://www.ncbi.
nlm.nih.gov/BLAST/). Using the comparative Ct method,
the amount of target sequence in unknown samples was
normalized to Hu or 16S reference.
Protein isolation, mass spectrometry and immunoblots
For the preparation of the protein extracts, bacteria were
grown until the exponential or stationary phases and the
cells are pelleted for 10 min at 4◦C (8000g). To purify the
extracellular proteins, the supernatants were collected and
precipitated with 10% trichloroacetic acid. The precipitates
were washed with ice-cold acetone and loaded onto SDS-
PAGE gels according to (21) and stained with Coomassie
blue R-250. The proteins of interest were extracted from
the gel, digested with trypsin and the peptides identified by
MALDI MS/MS and RP-HPLC/NanoLC/ESI-MS-MS.
For the total protein extractions, pellets of 2-ml cultures
were washed with TE (50 mM EDTA, 50 mM Tris pH
7.5), and suspended in 0.2 ml of the same buffer contain-
ing 0.1 mg/ml lysostaphin. Following incubation at 37◦C
for 10 min, the samples are boiled for 5 min and ana-
lyzed by SDS-PAGE. For the immunoblots, proteins were
transferred to PVDFmembranes (Immobilon-P,Millipore)
and incubated with polyclonal anti-autolysin antibodies (a
gift from Dr Sugai, Hiroshima University, Japan, (22). Sig-
nals were visualized using a STORM 840 Phosphor-Imager
(Molecular Dynamics).
Toeprints and gel retardation assays
Annealing mixtures containing 0.15 pmol of unlabeled
atl154 mRNA (154 nts, including the mRNA 5′-UTR, start-
ing with three additional Gs for transcriptional efficiency)
and 1.5 pmol of labeled primer in 20 mM Tris-acetate (pH
7.5), 60 mM NH4Cl and 1 mM DTT were incubated for 1
min at 90◦C and quickly chilled on ice for 1 min. Renatu-
ration proceeded in 10 mMMgCl2 at 20◦C for 15 min. The
influence of SprC (a 150 nt-long synthetic transcript with
3 additional Gs at the 5′-end for transcription efficiency),
SprC78–89 (a 138 nt-long RNA) or SprC55–67 (a 137 nt-
long RNA) was assayed by adding increasing amounts of
each RNA (7.5 to 30 pmol) to the annealing mixtures and
incubating for 5 min at 37◦C. The purified E. coli 70S ribo-
somes was diluted in the reaction buffer in the presence of 1
mMMgCl2, and then activated for 15min at 37◦C. For each
sample, 0.3 pmol of 70S ribosomes was added, followed by
5min incubation at 37◦C and adjustment of theMgCl2 con-
centration to 10 mM. After 10 min at 37◦C, 10 pmol of un-
charged tRNAfMet were added and the samples incubated
for 5 min at 37◦C. The cDNAs were synthesized using three
units of AMV RT (New England Biolabs, Ipswich, USA)
for 15 min at 43◦C. Reactions were stopped by adding 10
l of loading buffer II (Ambion, Foster City, USA). The
cDNAs were loaded and separated on a urea 8% PAGE
gel. The toeprint position on atl154 mRNA was determined
by DNA sequencing. The results were analyzed on a Phos-
phorImager. For the electrophoretic mobility shift assays,
the atl154 mRNA with SprC or SprC78–89, or SprC55–67
RNAs were denatured in 80 mM Hepes (pH 7.5), 330 mM
KCl and 4 mMMgCl2 for 2 min at 80◦C, chilled on ice and
refolded for 20 min at 20◦C. For the binding reaction (10
l reaction volume), the incubation was for 30 min at 30◦C.
0.005 pmol of labeled atl154 mRNAwas incubated with 6 to
200 pmol of unlabeled SprC for Kd determination, or with
the mutants from 5 to 40 pmol. To demonstrate specificity,
250 or 500 pmol of unlabeled SprA2AS were added. The
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samples were supplemented with 10% glycerol (final con-
centration) and loaded on a native 8% polyacrylamide gel
containing 5% glycerol. The electrophoresis was performed
in 0.5X Tris-borate EDTA at 4◦C (100V). The results were
analyzed on a PhosphorImager.
Filter binding assays
0.5 pmol of labeled atl154 mRNA or SprC were incubated in
20 mM Tris-acetate (pH 7.5), 60 mM NH4Cl, 1 mM DTT
for 1 min at 90◦C and chilled on ice for 1 min. Renaturation
was performed in 10 mM MgCl2 at 20◦C for 15 min. Puri-
fiedE. coli 70S ribosomes were diluted in the reaction buffer
in the presence of 1 mMMgCl2 and activated for 15 min at
37◦C. For the samples containing 70S ribosomes, 5 pmol of
70S ribosomes were added, followed by 5 min incubation at
37◦C and the concentration of MgCl2 adjusted to 10 mM.
After 10 min at 37◦C, 25 pmol of uncharged tRNAfMet were
added and the samples incubated for 15 min at 37◦C. The
final volume was set to 20 l. For the binding assays, we
used nitrocellulose membranes (AppliChem, Pure Nitrocel-
lulose). After equilibrating the membrane with 50 l of re-
action buffer per well, the samples were loaded into the well
and sucked through. We washed twice with 50 l reaction
buffer and air-dried the membrane prior exposition onto a
phosphor imaging device. The results were analyzed on a
PhosphorImager.
ATL protein purification
A plasmid encoding the 6XHis-fusion ATL protein was a
gift from Dr C. Heilmann (Mu¨nster University, Germany).
Purification of the 6XHis-fusion ATL protein from an E.
coli culture containing plasmid pQatl was performed un-
der denaturing conditions. Its production, in E. coli, was
induced by supplementing the culture with 1 mM IPTG
during 3 h. The cell pellets were dissolved in a lysis buffer
(100mMNaH2PO4, 10mMTris-HCl, 8MUrea, pH 8) and
centrifuged. Supernatant fluid was loaded onto an ‘AKTA
purifier’ (GE Healthcare) equipped with a Ni2+ column.
The washes were performed with a buffer containing 100
mM NaH2PO4, 10 mM Tris-HCl and 8 M Urea, pH 6.3.
The ATL protein was eluted with a buffer containing 100
mM NaH2PO4, 10 mM Tris-HCl, 8 M Urea, pH 5.9 and
then with the same elution buffer at pH 4.5. ATL was
additionally purified under native conditions. The 6XHis-
fusion ATL protein was dialyzed against dialysis buffer (50
mM NaH2PO4, 300 mM NaCl, pH 8) and loaded onto an
‘AKTA purifier’ equipped with a Ni2+ column. The washes
and binding were performed with a buffer containing 500
mM NaCl, 50 mM NaH2PO4, 5 mM Tris-HCl and 5 mM
Imidazole, pH 8. The ATL protein was eluted with a buffer
containing 500 mM NaCl, 50 mM NaH2PO4, 5 mM Tris-
HCl, 250mMImidazole, pH 8. The fractions containing the
overexpressed His-tagged ATL were pooled and dialyzed
against 50 mM Tris-HCl pH 7.2. The purity of the protein
was verified by 10% SDS-PAGE and its concentration esti-
mated with a Qubit fluorometer (InVitrogen).
Animal infection experiments
Experiments were monitored in the central animal labora-
tory ARCHE-BIOSIT- Rennes and all protocols were ap-
proved by the ethics committee (agreement No. R-2011-PT-
01). Virulence levels of strain Newman, its isogenic dele-
tion mutant ΔsprC-pCN38 and the complemented strain
ΔsprC-pCN38sprC were compared using a murine intra-
venous sepsis model. Groups of 10 female Swiss mice, 6-
to 8-weeks old (Janvier Laboratories, Le Genest Saint Isle,
France) were inoculated intravenously with 200 l of bac-
terial suspensions containing 5×107 S. aureus cells in 0.9%
NaCl. The survival of the mice was monitored for 14 days
and the statistical significance of differences between groups
was evaluated using the Mantel-Haenszel test. A P-value
<0.05 was considered significant. Four days after inocula-
tion, mice were euthanized with CO2 and their kidneys ex-
cised. After photographs were taken, the organs were ho-
mogenized, diluted in 0.9% NaCl and plated on BHI agar
for determination of bacterial titers, expressed as log10 CFU
per pair of kidneys. The statistical significance of differences
between groups was evaluated using the Mann-Whitney U
test. A P-value <0.05 was considered significant. The sta-
bility of plasmid sprC-pCN38ΩsprC (encoding chloram-
phenicol resistance) in the complemented ΔsprC mutant
was assessed by plating randomly selected colonies grown
from kidney homogenates on nutrient agar containing chlo-
ramphenicol.
Statistical analysis of the data
For the statistical analysis of the data, the Mann-Whitney
andWilcoxon (animal infection experiments) tests were per-
formed, as indicated for each set of experiments (Figure leg-
ends), on at least three independent experiments, to evaluate
significance. The data were expressed as mean ± standard
deviations (SD).
RESULTS
SprC negatively controls the expression of the major au-
tolysin ATL in S. aureus
In a large-scale analysis of the S. aureus transcriptome, we
identified a small RNA, SprC (srn 3610, SRD database,
(13)), expressed from the genome of a converting phage
(14). We determined the 5′- and 3′-ends of SprC by RACE
(Rapid Amplification of cDNA Ends) mapping. They were
located, respectively, at positions 1918280 and 1918432
within the S. aureusNewman sequence. In strain Newman,
sprC is located in the νSAβ pathogenicity island (PI) that
contains several virulence factors (14). Another S. aureus
sRNA, SprD, also situated within a PI, has a positive role
on virulence (15). According to the location of sprC within
a PI, we postulated that it could also be involved in staphy-
lococcal pathogenesis. In order to identify molecular tar-
gets of SprC, we analyzed whether the sRNA modifies the
expression of the extracellular proteins that include viru-
lence factors, as reported (15). To achieve this goal, a sprC
deletion mutant was constructed by homologous recombi-
nation in strain Newman, isolated from a human infection.
Northern blots confirmed the absence of SprC expression
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Figure 1. S. aureus SprC sRNA (srn 3610) lowers the expression levels of the major autolysin ATL. (A) Monitoring the bacterial growth and SprC
expression levels, by Northern blots (OD600nm: 2), in S. aureus strains Newman (blue diamonds), Newman-sprC (pink rectangles). (B) Monitoring the
6 Nucleic Acids Research, 2015
in strain Newman-sprC and the growth curves of strains
Newman and Newman-sprC were identical (Figure 1A).
Overexpression of SprC was achieved using a ‘multicopy’
plasmid expressing SprC from its endogenous promoter,
with no impact on cell growth (pCN38-sprC, Figure 1B).
In the extracellular proteins extracted from strain
Newman-pCN38sprC, levels of an ∼85 kD protein de-
creased as compared to the isogenic Newman strain (Fig-
ure 1C, arrow). Proteins from that band were eluted, tryp-
tic digests were prepared and the fragments analyzed by
MALDI-TOF mass spectrometry. Twenty-three peptides
were identified (Table 1), all matching the sequence of
the major autolysin ATL protein encoded by atl (23).
The ATL proteins are associated with the bacterial sur-
face by ionic or hydrophobic interactions and have enzy-
matic (peptidoglycan-hydrolytic) and adhesive functions.
The ATL protein is detected within the cytoplasm as well
as at the cell surface and extracellularly, after cleavage (22).
An independent confirmation of the decrease in the au-
tolysin levels, when SprC expression is induced, was ob-
tained by monitoring the autolysin protein within a total
protein extract by immunoblots with anti-autolysin anti-
bodies (Figure 1D). The immunoblots detected five proteins
in the cellular extracts, with apparent molecular weights
of 138, 115, 85, 62 and 51 kDa (Figure 1D). According
to (22), the 138 kDa bi-functional ATL protein contains
both the amidase (Ami) and the glucosaminidase (GL) do-
mains that is processed into two intermediates of 115 and
85 kDa, both of which are subsequently cleaved to pro-
duce, respectively, an N-terminal amidase domain (Ami,
N-acetylmuramoyl-L-alanine amidase; 62 kDa) and a C-
terminally located glucosaminidase domain (GL,endo-b-
N-acetylglucosaminidase; 51 kDa, (23), that correspond to
the two lower bands detected by immunoblots (Figure 1D).
As additional and independent experimental evidence of
the negative regulation of ATL by SprC, immunoblots per-
formed in strain Newman ΔsprC indicated that the expres-
sion levels of the ATL protein were increased compared to
the isogenic Newman strain (Figure 1E).
ATL regulation by SprC is not at the transcriptional level but
SprC reduces ATL expression by pairing with the mRNA and
preventing ribosome loading
To determinewhetherATL regulation by SprC occurs at the
transcriptional level, we examined the effect of SprC on the
steady-state levels of atlmRNA. The atlmRNA levels were
monitored by quantitative PCR (qPCR), in strains New-
man WT-pCN38 and WT-pCN38sprC, using hu as a ref-
erence gene. The atlmRNAexpression profile was similar in
both strains, elevated early, decreasing at the E phase, rising
at the early S phase and decreasing thereafter (Figure 1F).
During S. aureus growth, the atl mRNA expression profile
is not influenced by stimulating SprC expression, indicating
that SprC induction does not modify the atlmRNA steady-
state level (Figure 1F). Thus, the regulation of ATL by SprC
is not at the mRNA accumulation level, implying that SprC
may prevent atl mRNA translation.
The above data prompted us to test for the existence of
an interaction between SprC and the atlmRNA that could
reduce the mRNA translation. We did electrophoretic mo-
bility shift assays (EMSA) to analyze duplex formation be-
tween SprC and a 154 nt-long atlmRNA fragment contain-
ing its 5′ UTR sequence (34 nt plus 3Gs at the 5′-end), fol-
lowed by the first 39 codons. SprC formed a specific com-
plex with the atl151 mRNA in vitro (Figure 2A, left panel),
suggesting that the atlmRNA is a direct target of SprC. The
estimated Kd between the two RNAs is approximatively 35
M, suggesting that additional ligandsmight be involved in
the recognition process between the two RNAs in vivo. The
binding between SprC and the atlmRNAwas specific, since
a ten-fold excess of an unrelated RNA, SprA2AS, was un-
able to displace SprC from a preformed ‘atl mRNA-SprC’
complex (Figure 2A, right panel). SprC secondary structure
was inferred by MFold structure prediction (24) and con-
sists of three stem-loops (H1-H3) connected by two single
strands (Figure 2B). SprC sequence comparison among the
currently published S. aureus genomes indicated a ∼98%
sequence conservation, with two base-pair compensatory
changes located within helices H1 and H3, whereas the ma-
jority of the other changes are within the predicted RNA
single strands (Figure 2B).
We conjectured that SprC could lower ribosome load-
ing to the atl mRNA ribosomal binding site (RBS). We
tested this hypothesis by performing toeprint analysis. A
ternary initiation complex consisting of purified ribosomes,
initiator tRNAfMet and the atl mRNA was formed. The
ribosome blocked the elongation of reverse transcription
and produced a toeprint 17 nt downstream from the AUG
initiation codon of the atl mRNA (Figure 2C). SprC re-
duced the toeprint in a concentration-dependent manner,
indicating that SprC inhibits ribosome binding onto the
atl mRNA RBS. It implies that the pairing interaction
between SprC with the atl mRNA negatively influences
translation initiation. A possible pairing between SprC and
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
bacterial growths and SprC expression levels, by Northern blots (OD600nm: 2) of Newman-pCN38 (blue diamonds) and Newman-pCN38sprC (pink
rectangles). The 5S rRNAs are the loading controls. (C) Coomassie staining of SDS-PAGE of the exoproteins in strain Newman overexpressing (WT-
pCN38sprC), or not (WT-pCN38), SprC (OD600 = 7). The arrows point to the reduced levels of a protein when SprC is overexpressed. (D) Immunoblot
analysis with anti-autolysin (anti-ATL) antibodies to monitor the levels of the ATL protein produced as five distinct translational products (23) in strain
Newman overexpressing (WT-pCN38sprC), or not (WT-pCN38), SprC. Reduced levels are detected for all the ATL protein products when SprC is
overexpressed. Northern blot analyses of SprC expression levels in strains ‘WT-pCN38’ and ‘WT-pCN38sprC’ demonstrating SprC overexpression when
collecting the exoproteins. 5S rRNAs are the loading controls, ‘Spa’ corresponds to ‘Surface proteinA’. (E) Lacking sprC increasesS. aureusATL expression
levels. Immunoblots with anti-ATL antibodies to monitor the expression levels of ATL in S. aureus wild type strain (WT) and its isogenic strain lacking
sprC (sprC). Northern blot analyses of SprC expression levels in strains ‘WT’ and ‘sprC’ demonstrating the absence of SprC expression in the mutant
strain. 5S rRNAs are the loading controls. (F) qPCR analysis of the atlmRNA expression levels during bacterial growth in strains Newman ‘WT-pCN38’
(black bars) and ‘WT-pCN38sprC’ (white bars). Using the comparative Ct method, the amount of RNAs was normalized against the expression of the
hu reference gene and referred to the Newman ‘WT-pCN38’ after 1 h of bacterial growth. The data shown are the mean and the error bars indicated
representing Standard Deviation (SD) are derived from three independent experiments.
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Figure 2. SprC (srn 3610) interacts with the atlmRNA to prevent ribosome loading; SprC secondary structure and SprC mutants enhancing or reducing
atlmRNA translation initiation. (A) (left panel). Complex formation between an atlmRNA fragment and SprC. Native gel retardation assays of purified
labeled atl154 mRNAwith increasing amounts of purified, unlabeled SprC. (right panel) Competition assays performedwith 5 to 10-fold excess of unlabeled,
unrelated SprA2AS RNA. (B) SprC secondary structure prediction. A careful sprC gene sequence comparison among 49 available staphylococcal genomic
sequences have evidenced two compensatory base pair changes maintaining base pairings within H1 and H3 (rectangles) and the other nucleotide changes
(circles) are located, for the most part, within predicted RNA single strands. The three Gs added at SprC 5′-end for transcription are in italic. (C) (left panel)
Toeprint assays on the atl154 mRNA in the presence of increasing concentrations of purified SprC, SprC55–67 or SprC78–89. ‘-’ indicates the absence of
purified 70S ribosomes. The arrow points to the location of the experimentally-determined toeprint. U, A, G and C refer to the atl mRNA sequencing
ladders. (right panel) Quantitations of the toeprints on the atl mRNA in the presence of increasing concentrations of SprC (white), SprC55–67 (black) or
SprC78–89 (gray). Without any RNAs, the amount of toeprints was arbitrarily set to 100. The data and error bars, representing SD, indicated are derived
from three to six independent experiments. Two and three asterisks corresponded to the P-values≤0.01 and≤0.001, respectively. (D) Native gel retardation
assays of purified labeled atl154 mRNA with increasing amounts of purified, unlabeled SprC or SprC78–89.
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Table 1. Mass spectrometry identification of the bi-functional ATL autolysin protein by detecting 23 autolysin peptides
Observed Mr (expected) Mr (calculated) Peptides
1000.5056 999.4984 999.5349 K.DLNVQNLGK.E
1045.5361 1044.5288 1044.5564 K.ASKQQQIDK.S
1151.5647 1150.5574 1150.6023 K.LYTVPWGTSK.Q
1164.5835 1163.5762 1163.5935 K.VTTFSASAQPR.S
1213.5896 1212.5824 1212.6179 K.LYSVPWGTYK.Q
1310.7420 1309.7348 1309.7466 K.IAQVKPNNTGIR.A
1391.6556 1390.6483 1390.6292 K.IEEDYTSYFPK.Y
1447.6911 1446.6839 1446.6779 K.FYLVQDYNSGNK.F
1466.7259 1465.7186 1465.7161 K.QVAGSVSGSGNQTFK.A
1671.7965 1670.7892 1670.7801 K.YLGGTDHADPHGYLR.S
1696.8794 1695.8721 1695.8580 K.YKPQVNSSINDYIR.K
1718.9045 1717.8972 1717.8999 K.SPVNVNQSYSIKPGTK.L
1749.8965 1748.8892 1748.9131 K.SPVNVMQTYTVKPGTK.L
1765.8677 1764.8604 1764.9080 K.SPVNVMQTYTVKPGTK.L + Oxidation (M)
1794.8242 1793.8169 1793.8908 K.QEAGAVSGTGNQTFKATK.Q
1866.8675 1865.8602 1865.8445 K.NNYQNAFVHAFVDGDR.I
2001.9170 2000.9098 2000.9115 R.SHNYSYDQLYDLINEK.Y
2019.0255 2018.0182 2018.0010 R.FINVEIVHTHDYASFAR.S
2216.1376 2215.1304 2215.1273 R.IIETAPTDYLSWGVGAVGNPR.F
2298.1750 2297.1677 2297.1652 K.NPTQNISGTQVYQDPAIVQPK.T
2640.4100 2639.4027 2639.3806 K.AYLVDTAKPTPTPTPKPSTPTTNNK.L
2841.4854 2840.4781 2840.4556 K.VAPWGTQSTTTPTTPSKPTTPSKPSTGK.L
3322.5774 3321.5701 3321.5120 K.TNTNVTNAGYSLVDDEDDNSENQINPELIK.S
the atl mRNA was detected between U74-U85 (SprC)/A+12-
A+23 (atl mRNA). Therefore, the capacity of a SprC mutant
lacking nucleotides U78-U89 (SprC78–89) to influence atl
mRNA translation was analyzed. As expected and com-
pared to SprC, SprC78–89 had an impaired ability to lower
translation initiation onto the atl mRNA (Figure 2C).
EMSA performed between SprC78–89 and the atl mRNA
reinforces further these results by showing that complex
formation is severely impaired (Figure 2D). Another SprC
mutant lacking G55-G67 (SprC55–67) was constructed, be-
cause it was predicted, based on SprC secondary struc-
ture, to destabilize helix H2, in turn possibly enhancing
its downregulation of atl mRNA translation. Indeed, in-
creasing amounts of SprC55–67 reduced the toeprint in a
concentration-dependent manner, significantly more than
SprC (Figure 2C), indicating that mutant SprC55–67 has in-
creased regulatory activity onto the atl mRNA than SprC.
As internal control for the toeprint assays, the putative in-
teraction between SprC and the purified ribosomes was
challenged experimentally by filter binding assays and Sup-
plementary Figure S1A shows that whereas the atl mRNA
associates with the ribosomes, SprC does not. Moreover,
EMSA performed between labeled SprC and the tRNAfMet
have not detected any interaction between the two RNAs
(Supplementary Figure S1B). These data indicate that SprC
does not interact with either ribosomes or tRNAfMet. Over-
all, the atl mRNA is a direct molecular target of SprC and
the sRNA likely reduces its protein expression levels by pre-
venting translation initiation, but the interaction between
the two RNAs is elaborate and will need further structural
investigations.
Implementing an S. aureus internalization assay in human
phagocytes
SprC lowers the expression of the major autolysin ATL.
ATL has implications in cell wall turnover, cell separation,
division, autolysis, and mediates S. aureus internalization
by endothelial cells (18,25). We hypothesized that SprC’s
regulation of ATL synthesis could influence bacterial up-
take by the host’s professional phagocytes. To test that as-
sumption, an assay was implemented monitoring S. aureus
uptake by human phagocytes, including THP1 monocytes
and macrophages. Flow cytometric internalization assays
were set up by using a THP1 monocyte cell line. The S.
aureus Newman cells were labeled with FITC. The human
THP1 cells were incubated with the bacteria. Various ra-
tios between the human cells and the bacteria were assayed,
and a 1:10 ratio was selected. Incubations were from 5 min
to 3 h, after which the extracellular bacteria were removed
by lysostaphin treatment. Phagocytosis was monitored by
flow cytometry. The absence of any remaining extracellular
microorganisms, after the lysostaphin treatment, was veri-
fied bymicroscopy (Figure 3A, panels 1 and 2) and confocal
microscopy showed S. aureus internalization by the human
host cells (Figure 3A, panel 3). Cytochalasin D, an actin de-
polymerizing agent, inhibits actin-dependent S. aureus up-
take by the host cells (26). Cytochalasin was used as an in-
hibitor of host cell S. aureus uptake, providing evidence that
the number of internalized bacteria reflects host cell uptake
into the intracellular compartment. Increasing amounts of
cytochalasin D drastically reduced the number of S. aureus
cells present in the humanmacrophages (Figure 3B). It indi-
cates that the number of internalized bacteria is dependent
on uptake into the intracellular compartment, demonstrat-
ing phagocytosis in our assay.
Atl facilitates S. aureus internalization by the human phago-
cytes
We analyzed the capacities of a S. aureus Newman atl-
deficient mutant (a gift from Prof. J. O’Gara, Dublin, Ire-
land), a complemented strain with a plasmid expressing the
protein (27) and an isogenic Newman strain to be internal-
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Figure 3. Implementing an S. aureus-host cell phagocytosis assay showing that Atl facilitates S. aureus uptake by the human phagocytes. (A) Human
THP1 cells are incubated for 1 h with FITC labeled S. aureus Newman cells (MOI 1:10). Coverslips are mounted with the ‘Vectashield mounting medium’
containing DAPI. The human cell nucleus is blue (DAPI) and the S. aureus cell wall is green (FITC). The extracellular bacteria were (panel 2), or not (panel
1), lysed with lysostaphin for 10 min. After the lysostaphin treatment, microscope imaging did not detect extracellular bacteria (compare panels 1 and 2).
The bacteria were also viewed by confocal microscopy (panel 3). In panel 3, the S. aureus cells are stained green (FITC), the host cells nuclei are blue (DAPI)
and the host cell membranes are gray, imaged by Differential Image Contrast (DIC). In panel 3, two orthogonal sections are presented, demonstrating
S. aureus internalization. (B) Staphylococcal phagocytosis by human macrophages as evidenced by Cytochalasin D treatment. Cytochalasin D-treated
THP1 macrophages were infected with S. aureus (Newman) for 2 h followed by adding gentamycin for 1 h to remove the extracellular bacteria. Infected
THP1 macrophages without Cytochalasin D treatment served as internal positive controls. The data shown are the mean ± SD of three independent
experiments, each realized in triplicates. The data are considered highly significant for P-values ≤0.01 (**). (C) The major autolysin ATL facilitates S.
aureus internalization in human professional phagocytes. Amount of labeled THP1 cells after the internalization of FITC-labeled S aureus Newman
strains (1), Newman strain in the presence of pLI50atl (2), strain lacking atl expression (3) or atlNewman strain complemented with pLI50atl (4). FITC
labeled S. aureus strains were incubated for 5 min, 1 or 3 h with the human THP1 monocytes (MOI 1:10). The cells were analyzed by flow cytometry. The
data shown are the mean ± SD of three independent experiments, each realized in triplicates. The data are considered significant for P-values <0.05 (*),
highly significant for P-values ≤0.01 (**) and extremely significant for P-values ≤0.001 (***).
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ized by the human THP1 cells. The absence of atl mRNA
expression in strainNewmanatlwas confirmed by qPCR,
as well as its expression in the complemented strain New-
man atl-pLI50 atl (not shown). Compared to a Newman
strain, flow cytometric internalization assays indicated that
theatlmutation reduced the ability of the Newman strain
to be internalized by the THP1 host cells by ∼20%. The ef-
fect was observed early, after 5 min incubation (Figure 3C).
Compared to an isogenic S. aureus strain, the internaliza-
tion ofNewmanΔatl by the human host cells was decreased
and that reduction was reversed by atl complementation
(Figure 3C). These experiments indicated that the ATL pro-
tein facilitates S. aureus internalization by human profes-
sional phagocytes and that its absence reduces uptake by
host cells.
SprC lowers internalization by human phagocytes and its ab-
sence increases S. aureus uptake
ATL protein facilitates S. aureus uptake by the host cells
and SprC reduces Atl protein expression. To test if SprC in-
fluences S. aureus internalization by the host cells, phagocy-
tosis of S. aureus strain Newman-sprC by human mono-
cytes was compared to an isogenic Newman strain. Host
cell internalization of strain Newman ΔsprC gradually in-
creased over time, reaching a level ∼40% higher than for
strain Newman (Figure 4). SprC was overexpressed from
a low copy (∼20–25 copies per cell) pCN38sprC plasmid
in which sprC was cloned with its endogenous promoter.
Strains Newman-pCN38 and Newman-pCN38sprC had
similar growth curves and Northern blots confirmed SprC
overexpression in the latter strain (Figure 4). qPCR quan-
tifications indicated a 50±10 fold increase in SprC expres-
sion levels in strainNewman pCN38sprC compared to the
strain carrying an empty plasmid (not shown). The level of
induction of SprC expression in strains with pCN38sprC
reduced the amount of internalized bacteria by the human
phagocytes by∼20% (Figure 4A).When the S. aureusNew-
man cells were transformed with a high copy (∼300–400
copies per cell) pCN35sprC plasmid, SprC expression was
significantly enhanced whereas bacterial growth was unaf-
fected (Figure 4B). qPCR quantifications of SprC levels in
strain Newman pCN35sprC, compared to the strain with
an empty plasmid, indicated a 500±50 fold increase in SprC
expression (not shown). Compared toNewman pCN35, the
number of Newman pCN35sprC bacteria internalized by
the human monocytes was reduced by ∼40% (Figure 4A).
Inducing SprC expression reduces S. aureus uptake by the
host cells and the effect increases with the amount of SprC
produced.
The influence of SprC on S. aureus phagocytosis was
also evaluated in humanmacrophages, whose primary roles
are to ingest foreign particles and infectious microorgan-
isms. Phagocytosis of S. aureus strain Newman-sprC by
PMA-induced THP1macrophages was compared to an iso-
genic Newman strain. Host cell internalization of strain
Newman-sprC was significantly enhanced compared to
strain Newman (Figure 5A). A trans-complemented New-
man sprC-pCN38sprC strain was constructed. North-
ern blots confirmed the re-expression of SprC in strainNew-
man sprC-pCN38sprC, and its growth was identical
to that of the strain Newman-sprC-pCN38 (Figure 5C).
Conversely, the phagocytosis of a trans-complemented
strain (NewmansprC-pCN38sprC) was decreased com-
pared to a Newman sprC-pCN38 strain. Interestingly,
bacterial release from the THP1 macrophages, after 4 days,
was significantly increased in the absence of the sRNA,
and reduced in the trans-complemented strains (Figure 5B).
Therefore, these observations suggest that the bacteria lack-
ing SprC could possess higher virulence by a higher uptake
and release from the immune host cells.
To provide experimental evidence about a link between
the ATL and SprC regarding the S. aureus internaliza-
tion phenotype, we purified the ATL protein and moni-
tored its influence on phagocytosis of S. aureus strain New-
man lacking sprC, in comparison with strain Newman (at-
tempts to construct a sprC-Δatl double mutant failed).
Pre-incubation of the macrophages with a purified full-
length ATL protein, dose-dependently reduced internaliza-
tion ofS. aureus bacteria lacking SprC, but has no or limited
effects on S. aureus bacteria expressing SprC (Figure 5D).
This result suggests that the effect of SprC on phagocytosis
is mediated, at least in part, by its regulatory action onto
ATL.
SprC attenuates S. aureus virulence and its induction lowers
bacterial spread
S. aureus survives and multiplies within several host cells
including endothelial and epithelial cells, keratinocytes, fi-
broblasts and osteoclasts (28). Intracellular S. aureus uses
human phagocytes, especially the neutrophils, to travel and
infect distant sites (29). Bacteria lacking sprC may use the
host phagocytes for dissemination and multiplication into
the colonized host, in turn providing a significant advan-
tage during infection and spread into the infected hosts.
To assay that hypothesis, the implication of SprC expres-
sion was tested in a mouse systemic infection model, as per-
formed for SprD (15). The virulence of strain Newman-
sprC was significantly and reproducibly enhanced, with
half the animals already deceased at day 9 of infection (Fig-
ure 6A), five days earlier than what is observed with strain
Newman. Compared to strain Newman-sprC-pCN38,
the virulence of the trans-complemented strain Newman
sprC-pCN38sprC was partially restored (Figure 6B).
After day 6 of infection, the in vivo persistence of plasmid
pCN38sprC in the Newman sprC-pCN38ΩsprC com-
plemented strain was verified in selected colonies obtained
from mice kidney homogenates. All the selected colonies
retained chloramphenicol resistance, a specific marker of
pCN38. In a different intravenous infection experiment, the
animals were sacrificed at day 4, the kidneys of groups of
fivemice inoculated with strainsNewman,NewmansprC,
NewmansprC-pCN38 and the trans-complementedNew-
man ΔsprC-pCN38sprC strain were collected and vi-
able bacteria counted. Kidneys of mice inoculated with the
ΔsprC mutant are swollen and displayed mottled discol-
oration with numerous abscesses, whereas those of mice in-
oculated with strain Newman are homogenously red-brown
with only a few abscesses (Figure 6C). Kidneys of mice
infected with the SprC-complemented strains display ho-
mogenous coloration with very few abscesses (Figure 6C).
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Figure 4. SprC reduces S. aureus internalization by human monocytes and its absence augments phagocytosis. (A) Percentage of THP1 cells labeled with
FITC after S aureus internalization. FITC labeled S. aureus Newman and Newman-sprC, Newman-pCN38 and Newman-pCN38sprC, Newman-
pCN35 and Newman-pCN35sprC were incubated with the human monocytes (MOI 1:10) for the indicated times. The cells were analyzed by flow
cytometry. For a direct comparison of the S. aureus strains, we set up the labeling of control strains ‘Newman’, ‘Newman-pCN35′ and ‘Newman-pCN38’
arbitrarily at ‘10’. The data presented and the error bars indicated are the mean ± SD derived from three independent experiments (p* < 0.025). (B)
Lacking or stimulating SprC expression in vivo does not impact S. aureus growth. Monitoring bacterial growth and SprC expression levels, by Northern
blots (OD600nm = 2), in S. aureus strains Newman pCN35 (blue) and Newman-pCN35sprC (pink). The 5S rRNAs are the loading controls. The data
presented are the mean ± SD of three independent experiments realized in triplicates. The data are considered significant for P-values < 0.025 (*).
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Figure 5. SprC reduces S. aureus internalization by human macrophages and its absence augments phagocytosis and bacterial release from the host cells.
(A) Number of S. aureus cells (CFU) after internalization. Newman, Newman-ΔsprC, Newman-ΔsprC pCN38 and Newman-sprC pCN38sprC cells
were incubated with the THP1 macrophages (MOI 1:25) for 2 h. The non-phagocytosed bacteria were killed by culturing in medium containing 50 g/ml
gentamycin for 24 h. The medium was then replaced with fresh media for up to 4 days. (B) After 4 days, colony counts correspond to the bacteria that
were released by the human macrophages. The data presented are the mean ± SD of three independent experiments realized in triplicates. The data are
considered highly significant for P-values ≤0.01 (**). (C) Monitoring bacterial growth and SprC expression levels, by Northern blots (OD600nm = 2), in S.
aureus strains Newman ΔsprC-pCN38 (pink) and Newman ΔsprC-pCN38sprC (blue). The 5S rRNAs are the loading controls. Each blot presented is
from identical experiments. (D) Inhibition of S. aureus strain NewmanΔsprC phagocytosis by the THP1macrophages by adding increasing concentrations
of purified ATL protein (right panel) whereas exogenous ATL has limited, if any, effects on S. aureus strain Newman internalization (left panel).
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Figure 6. SprC attenuates the virulence and spread of a S. aureus clinical isolate on infected mice. (A) Survival probability plots (Kaplan-Meier) of mice
infected either with S aureusNewman (blue, 5.107 cfu per mouse) or isogenic S. aureusNewman-ΔsprC (red; 5.107 cfu); 0.05< P-value< 0.1. Groups of 10
‘six to eight-weeks old’ Swiss mice were inoculated intravenously with 5.109 bacteria and monitored daily for 2 weeks. The Mantel-Haenszel test P-value
is between 0.01 and 0.05. The results are representative of three independent experiments representing 30 mice per strain. (B) Survival probability plots
(Kaplan-Meier) of mice infected either with S. aureus Newman-ΔsprCpCN38 (blue; 5.107 cfu) or S. aureus Newman-ΔsprCpCN38sprC (red, 5.107 cfu
per mouse); The Mantel-Haenszel test P-value is lower than 0.01. Results are representative of three independent experiments representing 30 mice per
strain. (C) Recovery of S. aureus from the kidneys of infected mice four days after bacterial challenge. Groups of 5 mice were inoculated intravenously with
the indicated strains. Each individual is indicated by a circle symbol, with mean bacterial titers as red lines. The Mann-Whitney test P-value is between
0.01 and 0.05. The red line represents the mean value of 5 mice. Bottom: Macroscopic aspects of the recovered kidneys after intravenous infection with the
respective S. aureus strains.
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Results of the macroscopic observation are confirmed, in
the same experiment, by viable bacteria counts per kidney
pairs for the different strains (Figure 6C). Comparing the
viable bacteria number per kidney in strains Newman ver-
sus Newman-sprC, and Newman-sprC-pCN38 versus
Newman-sprC-pCN38sprC, using the Mann-Whitney
U test, indicates a significant P-value (<0.05). Altogether,
these results indicated that SprC has a negative impact on
the virulence of a S. aureus human isolate in an animal in-
fection model. SprC is therefore a virulence attenuator, re-
ducing bacterial spread into the colonized mice.
SprC is detrimental for S. aureus resistance in the presence
of a sublethal oxidative stress
Since SprC has a negative impact on virulence and host cell
internalization, the sRNA might also influence S. aureus
intracellular survival and persistence. In the presence of a
sublethal oxidative stress triggered by hydrogen peroxide (5
mM), strain Newman ΔsprC grew better than its isogenic
control strain (Figure 7A). The trans-complemented strain
Newman sprC-pCN38sprC has a restored growth phe-
notype in the presence of hydrogen peroxide (Figure 7B). In
the presence of hydrogen peroxide, inducing SprC expres-
sion substantially (Figure 7C) or moderately (Figure 7D)
delayed S. aureus growth, with respect to their internal con-
trols without sRNA induction. These data indicate that,
when S. aureus adapts to oxidative stress, the absence of
sprC is beneficial whereas inducing SprC expression is prej-
udicial for growth, in agreement with the experiments per-
formed at the cellular and animal levels.
SprC expression decreases after S. aureus host cell internal-
ization
Since the absence of SprC facilitates S. aureus host cell in-
ternalization (Figures 4 and 5), virulence (Figure 6) and al-
leviates resistance against an oxidant (Figure 7), we conjec-
tured that SprC expression might be diminished after bac-
terial uptake by the host cells. To test this hypothesis, total
eukaryotic and prokaryotic RNAs were extracted from hu-
man THP1 cells infected with labeled S. aureus strain and
deprived of extracellular bacteria Newman after 5 min, 1
h and 3 h of incubation, according to the experimental set
up described above. SprC expression levels were monitored
by qPCR. Within the infected host cells, SprC expression is
detected early and decreases∼4-fold after 1 h and∼10-fold
after 3 h (Figure 7E). As an internal control, the expression
of another S. aureus sRNA, transfer-messenger RNA (tm-
RNA), responsible of ribosome rescue and trans-translation
(30) was monitored during host cell phagocytosis. At the
three time points after S. aureus internalization, tmRNA
expression is maintained relatively stable over time (Fig-
ure 7E). The steady state levels of the hu mRNA, from 5
min to 3 h, were stable, indicating that the internalized S.
aureus cells are alive and transcriptionally active. The lower
expression of SprC within the ingested staphylococci could
increase their resistance to oxidative killing by the immune
cells, in turn promoting their dissemination into the colo-
nized host.
DISCUSSION
We report the case of a regulatory RNA expressed from the
accessory genome of a major bacterial pathogen, S. aureus,
that reduces virulence and host immune cell phagocytosis.
When SprC is not expressed, the bacteria are internalized
more, resist better to an oxidative burst, are released further
by the human phagocytes and possess increased virulence in
an animal infection model. SprC expression is detrimental
for bacterial spread into the colonized organisms, induces a
disadvantage for intracellular entry and resistance against
an oxidative environment. This may explain why its expres-
sion is turned off after host cell internalization. Another
sRNA expressed from the S. aureus core genome, RsaA,
is also a virulence suppressor that favors chronic infection
(16). Interestingly, whereas SprC lowers both the host cell
phagocytosis and the oxidative stress resistance, RsaA ren-
ders the bacteria more sensitive to opsono-phagocytosis by
the host PMNs. These two sRNAs, expressed from the core
(RsaA) and accessory (SprC) genome, attenuate staphylo-
coccal virulence by distinctmechanisms.Why doesS. aureus
express sRNAs exerting negative influences on pathogenic-
ity? sprC is detected in numerous S. aureus clinical strains
but its expression levels has not been monitored yet and we
also do not know if its negative impact on virulence can
be extrapolated to many clinical isolates. Nevertheless, re-
cent results in the lab performed on clinical strains isolated
from thirty patients with bloodstream infections indicate
that 30% of the strains lack sprC whereas only 20% of the
strains isolated from a set of thirty asymptomatic colonized
individuals lack sprC. A negative selection pressure against
sprCmay operate faster in the clinical strains than for those
present in the asymptomatic carriers, but this result should
be confirmed on a larger set of individuals.
sRNAs impacting host cell entry and invasion were re-
ported in several bacteria. The PI-encoded IsrM sRNA is
required for Salmonella invasion of epithelial cells, intra-
cellular replication inside macrophages, virulence and col-
onization in mice (31). Also, the expression of the AfaD
invasins that mediate entry of E. coli clinical isolates into
the host cells from various tissues is controlled and re-
duced by the AfaR antisense sRNA (32). As for the E. coli
AfaR, SprC protects the bacteria against their engulfment
by the human host cells. Neutrophils and monocytes strug-
gle to eradicate many invading pathogens, including S. au-
reus (33). In the Gram positive bacterium Listeria monocy-
togenes, several sRNAs are specifically expressed when the
bacteria are within the macrophages (34), but their impli-
cations for bacterial survival are unknown. In the Gram
negative Salmonella enterica serovar Typhi, two sRNAs,
RfrA and RfrB, are also required for optimal bacterial in-
tracellular replication in macrophages (35). The expression
of RNAIII, the effector of the agr quorum-sensing system
in S. aureus, is also modified after ingestion of S. aureus
clinical strain USA300 by the human neutrophils but, in
that case, its expression rapidly increases to produce -
hemolysin and, in turn, to trigger PMN lysis (36). We mon-
itored RNAIII expression levels, by qPCR, on the total eu-
karyotic and prokaryotic extracted RNAs, during human
THP1 infection by labeled S. aureus strain Newman. After
infection, the expression of RNAIII reproducibly increases
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Figure 7. SprC reduces S. aureus resistance toward hydrogen peroxide and its expression level decreases in internalized bacteria. Growth curves ofNewman,
Newman-sprC(A), Newman-sprC-pCN38 andNewman-sprC-pCN38sprC (B), Newman-pCN35’, ‘Newman-pCN35sprC’ strains (C), ‘Newman-
pCN38’ and ‘Newman-pCN38sprC’ (D), after exposure to 5 mM hydrogen peroxide (H2O2). Optical density was measured using the spectrophotometer
Biotek Synergy from 0 for 24 h. Growth curves are representative of three experiments. (E), SprC expression levels decrease in bacteria internalized by
human monocytes. Monitoring the expression levels of SprC (dark gray) and of tmRNA (light gray) by qPCR during phagocytosis of S. aureus wild-type
strain Newman. The bacteria were labeled by FITC, incubated with the human monocytes (MOI 1:10) for the indicated periods of times and total RNAs
extracted. Using the comparative Ct method, the amount of sRNAs was normalized against the expression of the hu reference gene and referred to the
internalized bacteria after 5 min of phagocytosis. The data presented are the mean ± SD of three independent experiments realized in triplicates. The data
are considered significant for P-values <0.05 (*) and extremely significant for P-values ≤0.001 (***).
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(6±1-fold) compared to the non-internalized bacteria (not
shown). Therefore, in clinical strain Newman, the expres-
sion of another S. aureus sRNA is modified upon host cell
uptake for survival and escape immune clearance. Is there a
functional link between SprC and RNAIII? Preliminary ex-
periments have monitored, by Northern blots, the RNAIII
levels during S. aureus growth in strains lacking or overex-
pressing SprC. At three time points during growth, RNAIII
levels were not influenced by the presence/absence of SprC
(not shown). These recent examples, including our findings,
indicate that once bacterial pathogens are internalized, the
expression of dedicated sRNAs and various toxins can be
required for their intracellular persistence and growths.
The human phagocytes are the first line of host defenses
against the invading pathogens. Intracellular bacterial per-
sistence includes ‘phagosome-lysosome’ fusion inhibition,
survival inside the phagolysosomes and cytoplasm escape
(37). When the bacteria survive, multiply and are released
from the host cells, phagocytosis becomes an advantage for
colonization and spread.Within the host phagocytes, S. au-
reus cells lacking SprC possess a higher ability to dissem-
inate and spread, ultimately stimulating the overall infec-
tious process. S. aureus phagocytosis by neutrophils induce
global changes in gene expression, including proteins in-
volved in resistance to oxidants (9). In S. aureus, the expres-
sion of many protein-encoding genes, including virulence
genes, is modified in response to an oxidative stress (38,39).
When S. aureus is phagocytosed, it faces and resists the host
defenses and resides in phagosomes containing antimicro-
bial peptides, proteolytic enzymes and reactive oxygen in-
termediates. The aim of the reactive oxygen species secreted
by the host cells is to destroy the engulfed bacteria. The in-
creased virulence of bacteria lacking SprC could be linked
to its higher survival rate in an oxidative environment such
as the phagolysosome. It suggests a tight coupling between
resistance against oxidants and bacterial virulence, exempli-
fied here by SprC. Future studies should address if SprC is
involved in S. aureus phagosomal escape (40).
We identified one direct molecular target of SprC whose
expression is down-regulated during translation initiation,
by antisense pairings, the ATL staphylococcal autolysin.
Many sRNAs are multifunctional and it might also be the
case of SprC, having additional regulatory functions in-
volved in S. aureus fitness with its environment. The interac-
tion between SprC and the atlmRNA is weak and complex,
probably implying the existence of additional RNA and/or
protein associates involved in the interaction. This is of no-
ticeable interest in the S. aureus sRNA field because, until
now, there are no facilitator/chaperone involved in RNA-
RNA interactions characterized in this bacterium. In ad-
dition to its positive implication in host cell phagocytosis,
ATL has activities in cell division, autolysis and biofilm for-
mation (41), suggesting that SprC may also influence these
bacterial functions. Preliminary experiments reported here
suggest that SprC influences host phagocytosis, at least in
part, by its control of ATL expression. The functional link
between SprC and Atl regarding phagocytosis could there-
fore be established. StrainΔsprC expresses moreATL at the
bacterial surface, compared towild-type (Figure 1E), conse-
quently predicted to interact more efficiently with the ATL
receptors located at the surface of the human phagocytes,
therefore increasing bacterial phagocytosis. When the ATL
protein is provided externally, it binds to and blocks some
of the human phagocytes receptors, subsequently prevent-
ing bacterial uptake via these ATL receptors. Thus, the pro-
gressive decrease of internalized staphylococci lacking sprC,
when the ATL is provided externally, may be rationalized
by the above arguments. This is probably not observed in
the case of the wild-type cells because they express lower
amounts of ATL at the bacterial surface (Figure 1E) and,
therefore, may be less affected by the blocking of the ATL
receptors from the human phagocytes via the ‘externally’
provided ATL. The physiological associations and implica-
tions between the S. aureus phagocytosis, SprC and ATL
‘triumvirate’ are currently being addressed experimentally.
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